ExecuPharm, a provider of pharmaceutical clinical research support services, has suffered a data security incident that has reportedly been identified as a CLOP ransomware attack, coupled with a corresponding data leak.
Security experts have expressed concern that cybercriminals will target health care organizations at a time when their services may be needed to help respond to the ongoing COVID-19 pandemic. It was already reported last month that the actors behind Maze ransomware were actively extorting Hammersmith Medicines Research (HMR), a UK-based clinical research organization that's been preparing to play a potential role in testing vaccine candidates for the novel coronavirus.
Now comes an assault against ExecuPharm – a King of Prussia, Penn.-based subsidiary of biopharmaceutical services company Parexel – which provides the pharma industry with such offerings as clinical monitoring, medical monitoring, site contracts and vendor sight. It is unclear to what extent ExecuPharm is providing services that support COVID-19 research efforts.
Please register to continue.
Already registered? Log in.
Once you register, you'll receive:
The context and insight you need to stay abreast of the most important developments in cybersecurity. CISO and practitioner perspectives; strategy and tactics; solutions and innovation; policy and regulation.
Unlimited access to nearly 20 years of SC Media industry analysis and news-you-can-use.
SC Media’s essential morning briefing for cybersecurity professionals.
One-click access to our extensive program of virtual events, with convenient calendar reminders and ability to earn CISSP credits.